The purchase price is only the beginning. The other question: does the technology build capacity that survives the trial? Read these two companion articles on hidden costs and what South Africa’s trial sites teach global research.

Show Post

Before asking whether your team can run the analysis, ask whether it can explain the research question and recognize when specialist input is needed. Knowing how to use a method is only part of knowing when to trust it.

Show Post

An imaging growth forecast should come with an infrastructure plan. Virtua’s experience puts vendor security, reliable data routing, and staff training at the center of that conversation.

Show Post

This is a useful pairing: a narrow, risk-based framework for deploying AI alongside a reminder that adoption depends on more than technical fluency. If younger researchers are more skeptical, organizations need to address purpose, governance, and trust—not just offer training on the interface.

Show Post

Accelerated approval can bring promising therapies to patients sooner, but it does not remove the need to confirm clinical benefit. The key question: is the pathway compressing a completed evidence plan, or skipping the evidence altogether?

Show Post